MedTrace Logo

The Role of Probiotics in Preventing Recurrent Urinary Tract Infections in Pregnant Women

NCT06429358 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-05-28

No results posted yet for this study

Summary

Urinary tract infections (UTIs) are a significant public health problem affecting more than 150 million people worldwide and causing a significant economic impact of approximately US$ 6 billion annually. It is one of the most common infectious diseases after upper respiratory tract infections. More than 50% of women and at least 12% of men will be affected by urinary tract infections in their lifetime. The probiotic supplement was delivered as easy-to-swallow capsules specifically prepared to maintain the viability and stability of the Lactobacillus rhamnosus GG strain throughout the research period. Participants were told to take the probiotic supplement with water to maximise absorption and efficiency, ideally after meals.

Conditions

Interventions

DIETARY_SUPPLEMENT

Lactobacillus rhamnosus

The probiotic supplement was delivered in the form of easy-to-swallow capsules.

OTHER

Control Group

Participants in the control group were given a placebo that looked, tasted, and felt just like the probiotic pill.

Sponsors & Collaborators

  • Frontier Medical and Dental College, Abbotabad

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-23
Primary Completion
2023-11-14
Completion
2024-01-15

Countries

  • Pakistan

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06429358 on ClinicalTrials.gov